Ann: Trading Halt, page-20

mate, I resonate and understand how you feel. However despite this, the story is even more compelling since the last funding round - if you were to glean a viewpoint outside of the AU/ASX the unencumbered valuation of VP-001 and PYC-001 as pure play IP assets is potentially worth 2.5x (worst case) to 4x (best case) that of our current market cap pre-first dose.

But the wild card is the value of forward looking unannounced program milestones and the ascending look through valuations reap-able to a patient cornerstone investor willing to take a LT position on the registry (I doubt it’ll be local).